Innovation is the key driving force in the cancer market, creating strong opportunities for biotech and pharma companies to launch new products and benefit from high volume sales and a strong competit ...
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...
The patient pool for cancer therapies is rising at a higher rate than the growth rate in population across the ten Latin American pharmaceutical markets, a trend primarily driven by the rising life ex ...
IntroductionThe 11 tumor types covered in this report will account for over 2.3 million new cases of cancer in 2006 in the seven major pharmaceutical markets. Despite the emergence of targeted ther ...
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...
The cancer market has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of established and emerging biotechnology and ph ...
IntroductionUnmet needs across the cancer market remain high, with most therapies conferring low levels of specificity and high toxicity. Therapeutic cancer vaccines offer an attractive therapeutic ...
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...
IntroductionPancreatic adenocarcinoma is the fifth leading cancer-related cause of death and is thus a major health issue in the developed world. Its aggressive nature and resistance to conventiona ...
